Facebook Instagram X-twitter Linkedin

Exosomas (Wharton’s Jelly) -100 Bill

Table of Contents

  • Quickstart Highlights

Exosomes (Wharton’s Jelly) – 100 Billion protocols focus on extracellular vesicles derived from Wharton’s Jelly mesenchymal stem cells. These nano-sized signaling particles are studied for their role in cellular communication, tissue repair signaling, and regenerative support. They may help modulate inflammation and support recovery processes in various tissues. This guide outlines a subcutaneous or localized application approach for the 100 billion particle vial format.

  • Reconstitute: Add 2.0–4.0 mL bacteriostatic saline or approved diluent → concentration adjusted based on volume
  • Typical range: 25–100 billion particles per session (application-dependent)
  • Administration: Subcutaneous or localized (depending on protocol use case)
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the exosome application protocol.

  • Goal: Support cellular signaling, tissue repair, and recovery modulation
  • Schedule: Typically administered 1–2 times per week, depending on protocol goals
  • Dose Range: 25–100 billion particles per session
  • Use Context: Commonly used in regenerative wellness and recovery protocols
  • Dosing Protocol

Suggested approach for the 100 billion vial format.

  • Start: 25–50 billion particles per session to assess response
  • Target: 50–100 billion particles per session
  • Frequency: 1–2 times per week (or as part of a structured cycle)
  • Vial Duration: One 100 billion vial may last 1–4 sessions, depending on dosing strategy
  • Timing: Flexible; often spaced evenly throughout the week for consistency
  • Mechanism of Action

Wharton’s Jelly-derived exosomes are nanoscale extracellular vesicles that carry bioactive cargo such as proteins, lipids, mRNA, and microRNA. These vesicles act as intercellular messengers, influencing recipient cell behavior and signaling pathways.

Research suggests they may support tissue repair by modulating inflammation, promoting angiogenesis, and enhancing cellular communication in damaged or stressed tissues. Unlike cell-based therapies, exosomes do not replicate but instead deliver regulatory signals that may help guide regenerative processes. Preclinical studies indicate potential roles in wound healing, musculoskeletal recovery, and immune modulation.

  • Potential Benefits & Side Effects

Observations based on preclinical and early-stage research.

Potential Benefits:

  • May support tissue repair and regenerative signaling
  • May help modulate inflammation and immune response
  • May support recovery in musculoskeletal and soft tissue systems
  • May enhance cellular communication and repair pathways

Possible Side Effects:

  • Generally well tolerated in early research settings
  • Mild injection-site irritation or temporary discomfort
  • Possible transient fatigue or flu-like sensations in some cases
  • Long-term human safety and standardized dosing are still under investigation